Is peginterferon alfa-2b plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom?

被引：0
|
作者：
Wong, JB
Rosenberg, WM
Manns, MP
McHutchison, JG
Davis, GL
Albrecht, JK
Group, IHIT
机构：
[1] Tufts New England Med Ctr, Boston, MA USA
[2] Univ Southampton, Southampton SO9 5NH, Hants, England
[3] Hannover Med Sch, Hannover, Germany
[4] Baylor Univ, Med Ctr, Dallas, TX USA
[5] Duke Univ, Med Ctr, Duke Clin Res Inst, Raleigh, NC USA
[6] Schering Plough Res Inst, Kenilworth, NJ USA
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
625
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [11] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [12] Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C
    Yeh, Frank
    Gordon, Fredric D.
    FUTURE VIROLOGY, 2007, 2 (06) : 553 - 563
  • [13] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [14] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [15] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [16] Cost Effectiveness of Peginterferon Alfa-2b Combined with Ribavirin for the Treatment of Chronic Hepatitis C in Brazil
    Machado Fonseca, Marcelo Cunio
    Branco de Araujo, Gabriela Tannus
    Araujo, Denizar Vianna
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (03): : 191 - 199
  • [17] A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C
    Buti, M
    Medina, M
    Casado, MA
    Wong, JB
    Fosbrook, L
    Esteban, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) : 687 - 694
  • [18] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Sandoval, J.
    Mata, J.
    Gaytan, J.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25
  • [19] Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Luis Sandoval-Ramirez, Jorge
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Enrique Gaytan-Martinez, Jesus
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (03): : 267 - 273
  • [20] Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C
    Krawitt, EL
    Ashikaga, T
    Gordon, SR
    Ferrentino, N
    Ray, MA
    Lidofsky, SD
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 243 - 249
12345